{"product_id":"rybelsus-7mg-con-30-tabletas-semaglutina","title":"Rybelsus 7Mg with 30 Tablets (Semaglutide)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedication\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eAntidiabetic\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eRybelsus\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eSemaglutide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e30 tablets of 7 mg\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eNovo Nordisk\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eRybelsus is indicated for the treatment of type 2 diabetes in adults, as an adjunct to an appropriate diet and exercise. This medication helps improve glycemic control in patients with type 2 diabetes and can be used alone or in combination with other oral antidiabetic medications. Rybelsus works by mimicking the action of glucagon-like peptide 1 (GLP-1), which increases insulin secretion in response to meals, decreases glucagon release, and delays gastric emptying, contributing to the reduction of blood glucose.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Rybelsus tablet contains 7 mg of semaglutide as the active ingredient. It also contains excipients that facilitate the formulation and stability of the product.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eRybelsus is contraindicated in patients with a history of hypersensitivity to semaglutide or any of the components of the formulation. It should not be used in patients with type 1 diabetes, or for the treatment of diabetic ketoacidosis. It is also contraindicated in people with a history of pancreatitis, as well as in those with gastrointestinal conditions that alter drug absorption.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with kidney or liver disease, as well as in those with a history of pancreatitis. It is important to monitor renal function in patients treated with Rybelsus, especially in those with risk factors. Similarly, caution should be exercised in patients with a family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore at room temperature, between 15 °C and 30 °C. Protect from light and moisture. Do not use after the expiry date indicated on the package.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Novo Nordisk","offers":[{"title":"Default Title","offer_id":45848498012385,"sku":"7503007822901","price":4892.97,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/planogram__1__0aea5301-4d4c-4bb3-a54d-e9700d404e58.jpg?v=1744689245","url":"https:\/\/wecarepharma.mx\/en\/products\/rybelsus-7mg-con-30-tabletas-semaglutina","provider":"WeCare Pharma","version":"1.0","type":"link"}